As of 2025-06-13, the Relative Valuation of Ikena Oncology Inc (IKNA) is (70.72) USD. This relative valuation is based on P/E multiples. With the latest stock price at 1.40 USD, the upside of Ikena Oncology Inc based on Relative Valuation is -5151.2%.
The range of the Relative Valuation is (56.57) - (71.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 46.1x - 59.9x | 57.6x |
| Forward P/E multiples | 46.1x - 58.3x | 57.6x |
| Fair Price | (56.57) - (71.53) | (70.72) |
| Upside | -4141.0% - -5209.1% | -5151.2% |
| Date | P/E |
| 2025-06-06 | -1.16 |
| 2025-06-05 | -1.06 |
| 2025-06-04 | -1.09 |
| 2025-06-03 | -1.10 |
| 2025-06-02 | -1.04 |
| 2025-05-30 | -0.97 |
| 2025-05-29 | -0.96 |
| 2025-05-28 | -0.94 |
| 2025-05-27 | -0.96 |
| 2025-05-23 | -0.93 |
| 2025-05-22 | -0.94 |
| 2025-05-21 | -0.94 |
| 2025-05-20 | -0.92 |
| 2025-05-19 | -0.90 |
| 2025-05-16 | -0.90 |
| 2025-05-15 | -0.90 |
| 2025-05-14 | -0.88 |
| 2025-05-13 | -0.94 |
| 2025-05-12 | -0.93 |
| 2025-05-09 | -0.92 |
| 2025-05-08 | -0.88 |
| 2025-05-07 | -0.89 |
| 2025-05-06 | -0.91 |
| 2025-05-05 | -0.99 |
| 2025-05-02 | -1.02 |
| 2025-05-01 | -0.99 |
| 2025-04-30 | -1.03 |
| 2025-04-29 | -1.06 |
| 2025-04-28 | -1.03 |
| 2025-04-25 | -0.97 |
| 2025-04-24 | -0.99 |
| 2025-04-23 | -0.99 |
| 2025-04-22 | -0.97 |
| 2025-04-21 | -0.93 |
| 2025-04-17 | -0.90 |
| 2025-04-16 | -0.90 |
| 2025-04-15 | -0.93 |
| 2025-04-14 | -0.95 |
| 2025-04-11 | -0.90 |
| 2025-04-10 | -0.86 |
| 2025-04-09 | -0.90 |
| 2025-04-08 | -0.88 |
| 2025-04-07 | -0.84 |
| 2025-04-04 | -0.92 |
| 2025-04-03 | -0.98 |
| 2025-04-02 | -1.02 |
| 2025-04-01 | -1.02 |
| 2025-03-31 | -1.04 |
| 2025-03-28 | -1.08 |
| 2025-03-27 | -1.08 |